Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 6Unknown 3Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Plasma cell 2

Conditions

Multiple Myeloma 2Inflammation 1Fatigue 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × OTHER × Chromatin Immunoprecipitation Sequencing × Clear all
NCT05888636 2024-03-22

TEDROMM

Regina Elena Cancer Institute

Unknown
200 enrolled
Plasma cell

Multiple Myeloma

NCT05858203 2023-05-15

AATF/Che-1

Regina Elena Cancer Institute

Unknown
150 enrolled
Plasma cell

Multiple Myeloma

NCT03259438 2017-08-23

The Vitality Project for Fatigued Female Cancer Survivors

The Miriam Hospital

Phase NA Unknown
75 enrolled

Fatigue, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡